Skip to main content
All lobbying filings

PHILIPS HOLDING USA, INC.

Lobbying for PHILIPS HOLDING USA INC.

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$650,000.00
What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Massachusetts

Official filing document

 Government bodies contacted 6
  • Council of Economic Advisers (CEA)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • Veterans Affairs, Dept of (VA)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 9
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • S 1399
    Health Tech Investment Act
  • HR 6197
    Health Tech Investment Act
  • HR 5081
    Telehealth Modernization Act
  • S 2709
    Telehealth Modernization Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • HR 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
  • S 2296
    National Defense Authorization Act for Fiscal Year 2026
 Lobbying activity 9
Homeland Security

Reauthorization of the Cybersecurity Information Sharing Act (CISA) and retroactivity for lapsed period

Tariff (miscellaneous tariff bills)

Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.

Taxation/Internal Revenue Code

Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.

Medicare/Medicaid

S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform Extension of Medicare telehealth waivers - H.R. 5081/S. 2709 - The Telehealth Modernization Act (all sections) S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) H.R. 1 - the One Big Beautiful Bill Act - Section 71202, Temporary payment increase under the Medicare physician fee schedule to account for exceptional circumstances H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act - whole bill

Health Issues

Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof

Budget/Appropriations

FY 2025 Veterans Affairs Appropriations, in general with some focus on telehealth provisions FY 2025 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2025, including issues related to RATE and low helium MRIs

Veterans

U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)

Defense

H.R. 3838, National Defense Authorization Act - Sec. 863 (Requirement for Contractors to Provide Reasonable Access to Repair Materials), Sec. 892 (Inventory of technical data rights for weapon system sustainment), right-to-repair S. 2296, National Defense Authorization Act - Sec. 836 (Instructions for Continued Operational Readiness), right-to-repair Telehealth in DOD

Chemicals/Chemical Industry

EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem